Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis

A. Lo, Robert J. Stratta, M. F. Egidi, M. H. Shokouh-Amiri, H. P. Grewal, A. T. Kisilisik, J. Trofe, R. R. Alloway, L. W. Gaber, A. O. Gaber

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

Background: The impact of tacrolimus (TAC), mycophenolate mofetil (MMF) and steroid immunosuppression on cytomegalovirus (CMV) infection in combination with ganciclovir prophylaxis in simultaneous kidney-pancreas transplantation (SKPT) has not been well studied. Methods: A retrospective analysis was made of 75 SKPTs performed between 1 January 1996 and 7 January 1999. All patients received ganciclovir for 3 months, but CMV donor (D)+ / recipient (R) - patients received ganciclovir for 6 months. Results: 16/74 (22%) were CMV D+/R-, 25 (33%) D+/R+, 16 (22%) D-/R+, and 17 (23%) D-/R- (1 patient with unknown donor serology was excluded). The mean time to CMV infection was 198 days post-post-transplant. The incidence of either CMV infection or tissue invasive CMV disease was 16/74 (22%), including 9 (12%) with CMV infection and 7 (10%) CMV disease. The one-year patient, kidney, and pancreas graft survival rates were 91%, 89%, and 83%, respectively. The mean follow-up was 29 months (minimum of 12 months). CMV infection was not associated with an increased incidence of graft failure or mortality. The D+/R - group had the highest incidence of CMV infection (44%) compared with the other serologic groups (17%, P=0.02). Concurrent CMV and rejection occurred more frequently in the D+/R - than the other serologic groups (25% vs. 7%, P= 0.03). The D-/R- group had the best outcomes, with no CMV infection, improved kidney graft survival at the end of follow-up (82% vs. 72%, P= 0.04) and the highest event·free survival (no CMV infection, rejection, or graft loss) when compared to the other groups (76% vs. 33%, P<0.01). Conclusions: Compared to previous studies, ganciclovir prophylaxis delayed the onset and reduced the severity of CMV infection in patients receiving TAC, MMF, and steroids. Despite ganciclovir prophylaxis, CMV seronegative patients receiving CMV D+ organs had worse outcomes than seronegative recipients receiving CMV D- organs.

Original languageEnglish (US)
Pages (from-to)8-15
Number of pages8
JournalTransplant Infectious Disease
Volume3
Issue number1
DOIs
StatePublished - 2001

Keywords

  • Cytomegalovirus
  • Ganciclovir
  • Mycophenol ate mofetil
  • Simultaneous kidney-pancreas transplantation
  • Tacrolimus

ASJC Scopus subject areas

  • Transplantation
  • Microbiology (medical)
  • Immunology

Fingerprint Dive into the research topics of 'Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis'. Together they form a unique fingerprint.

Cite this